Paeds Vivas · infectious-diseases
Congenital syphilis and perinatal STIs — branching viva
Branching structured-oral viva on congenital syphilis and the perinatal sexually transmitted infections: the transplacental spirochaetal pathophysiology with the maternal-stage transmission gradient, the early snuffles phenotype and the late Hutchinson triad, the comparative maternal-and-neonatal serology, the benzathine penicillin maternal regimen and the ten-day aqueous penicillin neonatal course, penicillin desensitisation, neonatal herpes and ophthalmia neonatorum management, and the universal-screening prevention strategy.
On this page & tools
Target exams
Opening question
Examiner: Take me through this infant. What is the most likely diagnosis, and what is your frame for managing it? [3]
Candidate: The most likely diagnosis is early congenital syphilis. The combination of hepatosplenomegaly, a copper-coloured maculopapular rash on the palms and soles, generalised lymphadenopathy, and snuffles — the profuse blood-tinged nasal discharge teeming with spirochaetes — is classic, and the painful limb suggests osteochondritis with pseudoparalysis of Parrot. The maternal treatment gap, only ten days before delivery when four weeks is needed, confirms high risk. My frame is two-layered: confirm and treat this infant now, and run the public-health response to the maternal, partner and next-pregnancy risk. I would isolate for the infectious secretions, confirm with comparative serology, and start ten days of intravenous aqueous penicillin. [6]
Examiner: Why ten days of intravenous penicillin rather than a single benzathine dose? [6]
Candidate: Because the central nervous system must be penetrated to treat neurosyphilis, and benzathine penicillin does not achieve reliable CSF concentrations. A symptomatic infant — or one with confirmed disease — gets aqueous crystalline penicillin G intravenously for ten days. A single benzathine dose is reserved only for the fully asymptomatic, well-evaluated, low-risk infant whose mother was adequately treated and whose serology is reassuring. [6]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References6Show ledgerHide ledger
- [1]Gomez GB; Kamb ML; Newman LM; Mark J; Broutet N; Hawkes SJ Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ, 2013.PMID 23476094
- [3]Flores JM; Arguello E; Beddard R; Ahmed A; et al State-of-the-Art Review: Congenital Syphilis in the Modern Era: Current Strategies and Future Directions. Clin Infect Dis, 2026.PMID 41638217
- [5]Samies NL; Lakeman M; Cantey JR; et al Neonatal Herpes Simplex Virus Disease: Updates and Continued Challenges. Clin Perinatol, 2021.PMID 34030813
- [6]Workowski KA; Bachmann LH; Chan PA; et al Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep, 2021.PMID 34292926
- [13]Wendel GD Jr; Stark BJ; Jamison RB; Molina RD; Sullivan TJ Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med, 1985.PMID 3921835
- [14]Pessoa L; Atri S; Laca J; Guerra C; Perez K Clinical aspects of congenital syphilis with Hutchinson's triad. BMJ Case Rep, 2011.PMID 22670010